PIII Share Price Performance
US$4.32
-5.10 (-54.14%)
46.0% undervalued intrinsic discount
US$8.00
Fair Value
Price US$4.32
AnalystLowTarget US$8.00
AnalystConsensusTarget US$10.25
AnalystHighTarget US$20.00
Fair ValueUS$8.00
Share Pricen/a
P3 Health Partners Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
PIII Community Narratives
AN
Fair Value US$8 46.0% undervalued intrinsic discount
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$10.25 57.9% undervalued intrinsic discount
Rising Medicare Eligibility And Value-Based Care Will Expand Markets
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$20 78.4% undervalued intrinsic discount
Aging Demographics And Medicare Advantage Will Redefine Primary Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rising Medicare Eligibility And Value-Based Care Will Expand Markets
Key Takeaways Expansion in the Medicare market and shift to value-based care models position the company for sustained membership, revenue growth, and improved profitability. Technology investments, operational efficiencies, and stronger payer collaborations are creating measurable cost savings, margin expansion, and enhanced revenue opportunities.Read more
17
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$10.25
57.9% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
6.14% p.a.
Profit Margin
5.45%
Future PE
0.46x
Price in 2028
US$13.04
Aging Demographics And Medicare Advantage Will Redefine Primary Care
Key Takeaways Operational enhancements, advanced technology, and programmatic cost controls position P3 for meaningful margin and earnings growth beyond market expectations. Strong payer relationships, expanding joint ventures, and industry tailwinds in value-based care support higher, recurring revenue and significant market share gains.Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$20
78.4% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
4.32% p.a.
Profit Margin
5.27%
Future PE
2.12x
Price in 2028
US$56.22
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
Key Takeaways Regulatory and industry pressures threaten P3's profitability and margins, with potential for unfavorable reimbursement and increased medical costs. Failure to achieve operational improvements or keep pace with digital health trends could lead to sustained losses and market share erosion.Read more
1
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$8
46.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
4.23% p.a.
Profit Margin
5.39%
Future PE
0.83x
Price in 2028
US$22.5
Trending Discussion
Recently Updated Narratives
AN
PIII: Operational Progress And 2026 Earnings Ramp Will Drive Long-Term Upside
Fair Value: US$10.25 57.9% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Persistent Regulatory Risk And Consolidation Will Constrain Future Margins
Fair Value: US$8 46.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Demographics And Medicare Advantage Will Redefine Primary Care
Fair Value: US$20 78.4% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
P3 Health Partners Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -39.87
- -4.05%
- -9.07%
- 1,336.2%
About PIII
- Founded
- 2020
- Employees
- 360
- CEO
- WebsiteView website
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
